2015
DOI: 10.1007/s10753-015-0179-0
|View full text |Cite|
|
Sign up to set email alerts
|

The Neuroprotective Effect of Coumaric Acid on Spinal Cord Ischemia/Reperfusion Injury in Rats

Abstract: The main causes of spinal cord ischemia are a variety of vascular pathologies causing acute arterial occlusions. We investigated neuroprotective effects of coumaric acid on spinal cord ischemia injury in rats. Rats were divided randomly into four groups of eight animals as follows: control, ischemia, ischemia + coumaric acid, and ischemia + methylprednisolone. In the control group, only a laparotomy was performed. In all other groups, the spinal cord ischemia was performed by the infrarenal aorta cross-clampin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 28 publications
0
9
0
Order By: Relevance
“…Secondly, the function of neuro-inflammation was only tested in the ischemic stroke model. However, inflammation participates in different types of injuries, including central [3941] and peripheral nervous system [42]. Further studies are required to fully depict the role of inflammation in other neurological pathologies.…”
Section: Discussionmentioning
confidence: 99%
“…Secondly, the function of neuro-inflammation was only tested in the ischemic stroke model. However, inflammation participates in different types of injuries, including central [3941] and peripheral nervous system [42]. Further studies are required to fully depict the role of inflammation in other neurological pathologies.…”
Section: Discussionmentioning
confidence: 99%
“…1, 3, 5, and 7 days postoperatively, eight rats from each group were randomly selected for evaluation of hindlimb motor function by using the inclined plane test [ 31 ] and modified Tarlov scoring system [ 32 ].…”
Section: Methodsmentioning
confidence: 99%
“…In final remarks, addressing the rationale of the applied methodology, it has to be noted that the applied dose of PTX was within the range of those used in other experiments on rats: 100 mg/kg body weight vs. 30–300 mg/kg body weight [ 21 , 25 , 27 ], and its application at this dose prior to IRI was previously found by us to be nephroprotective, as opposed to intra- or post-IRI administration [ 10 ]. On the other hand, the dosage of MP (100 mg/kg body weight) was higher than that usually studied in IRI rat models (30 mg/kg body weight) [ 32 , 33 ]. This more intense steroid treatment was based on our previous experiments with MP doses ranging from 15 to 100 mg/kg body weight, which showed the long-term kidney protection from IRI only with the highest dosage [ 34 ].…”
Section: Discussionmentioning
confidence: 97%